What Did My Patient Actually Take? An Overview of Cannabinoids and Semi-Synthetic Cannabinoids

Register for our Next Live Webinar Presentation

What Did My Patient Actually Take? An Overview of Cannabinoids and Semi-Synthetic Cannabinoids

Date: January 22, 2026 | Time: 9am (CST) or 1pm (CST)

Please join us for an educational webinar on cannabinoids and semi-synthetic cannabinoids hosted by Dr. Kristin Hillman, Pharm.D., Clinical Pharmacist, Aegis Sciences Corporation. Dr. Hillman will discuss multiple aspects of cannabinoid and semi-synthetic cannabinoid products and their interpretation.

Objectives are:

• Review the cannabinoids and the semi-synthetic cannabinoids now available for testing at Aegis.
• Understand potential legal changes for hemp-derived semi-synthetic cannabinoids.
• Explain the differences between hexahydrocannabinol (HHC) and delta-10 THC.
• Compare the psychosis risk between cannabinoids and the semi-synthetic cannabinoids.
• Discuss differences between urine and oral fluid testing for cannabinoids and semi-synthetic cannabinoids.

This webinar will help healthcare providers better understand the emerging risks associated with the influx of cannabinoid and semi-synthetic cannabinoid products in the market and how their use may impact patient care and decision-making in clinical settings.